Chapter V

Literature Cited

1. Ahrens, E.H. 1979. Introduction to report of the task force on the evidence relating six dietary factors to health. Amer. J. Clin. Nutr. 32:2627-2631.
   
2. Akerele, O. 1993. Summary of World Health Organization guidelines for the assessment of herbal medicines. Herbalgram. 28:13-16. (Reprinted with permission from Fitoterapia. Volume LXIII. November 2, 1992. pp. 99-110.)
   
3. American Herbal Products Association. 1996. Written information submitted to the Commission on Dietary Supplement Labels. October 11.
   
4. American Law Institute. Restatement III Torts, 2 (1997).
   
5. American Law Institute. Restatement II Torts, 402A (1965).
   
6. Anonymous. 1997. $46-billion global nutrition market shows regional variation. Nutr. Bus. J. 2:1-7.
   
7. Bass, I.S.; Young, A.L. 1996. Dietary supplement health and education act: a legislative history and analysis. Washington, DC: The Food and Drug Law Institute.
   
8. Bayne, H.; Blumenthal, M.; Israelsen, L. 1996. A survey of regulations of herbal medicine in six industrialized nations. Executive summary. Traditional medicines research project. Austin, TX: American Botanical Council. Supplement to oral testimony by M. Blumenthal presented to the Commission on Dietary Supplement Labels.
   
9. Brevoort, P. 1996. The U.S. market for botanicals. Paper presented at the United States Pharmacopeia open conference: botanicals for medical and dietary uses. July 7-9. Washington, DC.
   
10. Calfee, J.; Pappalardo, J. 1989. How should health claims for foods be regulated? An economic perspective. Economic Issues. Bureau of Economics. Federal Trade Commission.
   
11. Chalmers, I.; Altman, D.G., eds. 1995. Systematic reviews. BMJ Publishing Group, London.
   
12. Clinton, W. 1994. Statement by the President. October 24. Office of the Press Secretary. The White House. Washington, DC.
   
13. Committee on Diet and Health. 1989. Methodological considerations in evaluating the evidence. In: Diet and Health. Implications for Reducing Chronic Disease Risk. National Academy Press. pp. 23-40.
   
14. Cordaro, J. 1996. President. Council for Responsible Nutrition. Oral testimony presented to the Commission on Dietary Supplement Labels. February 16. Washington, DC.
   
15. Council for Responsible Nutrition. 1997. Supplement news you can use. Dietary supplements: mass market share. Derived from Infoscan Information Research, Inc. Manhattan Beach, CA. p. 4.
   
16. Deighton, J. 1984. The interaction of advertising and evidence. J. Consumer Res. 11:763-770. As cited by Calfee, J.; Pappalardo, J. 1989. pp. 31.
   
17. Deighton, J. 1983. How to solve problems that don't matter: some heuristics for uninvolved thinking. Advances in consumer research. 10:314. As cited by Calfee, J.; Pappalardo, J. 1989. pp. 31.
   
18. de Smet, P.A.G.M.; Keller, K.; Hasen, R.; Chandler, R.F. 1997. Adverse effects of herbal drugs. Berlin: Springer-Verlag. Volume 3.
   
19. de Smet, P.A.G.M.; Keller, K.; Hasen, R.; Chandler, R.F. 1993. Adverse effects of herbal drugs. Berlin: Springer-Verlag. Volume 2.
   
20. de Smet, P.A.G.M.; Keller, K.; Hasen, R.; Chandler, R.F. 1992. Adverse effects of herbal drugs. Berlin: Springer-Verlag. Volume 1.
   
21. Edwards, R. 1997. The World Health Organization Collaborating Centre for International Drug Monitoring. Uppsala, Sweden. Personal communication with N. R. Farnsworth.
   
22. Evans, F.J. 1986. Naturally occurring phorbol esters. Boca Raton, FL: CRC Press, Inc.
   
23. Farnsworth, N.R. 1993. Relative safety of herbal medicines. Herbalgram. 29:36A-36H.
   
24. Federal Trade Commission. 1994. Enforcement policy statement on food advertising. Fed. Reg. 59:28388-28396.
   
25. Federal Trade Commission. 1983. Advertising substantiation program; request for comment. Policy statement regarding advertising substantiation. Fed. Reg. 48:10471-10475.
   
26. Food and Drug Administration. 1997. Food labeling; statement of identity, nutrition labeling and ingredient labeling of dietary supplements; compliance policy guide, revocation. Fed. Reg. 62:49826-49858.
   
27. Food and Drug Administration. 1997. Food labeling; requirements for nutrient content claims, health claims, and statements of nutritional support for dietary supplements. Fed. Reg. 62:49859-49868.
   
28. Food and Drug Administration. 1997. Food labeling; nutrient content claims: definition for "high potency" and definition of "antioxidant" for use in nutrient content claims for dietary supplements and conventional foods. Fed. Reg. 62:49868-49881.
   
29. Food and Drug Administration. 1997. Uniform compliance date for food regulations. Fed. Reg. 62:49881-49883.
   
30. Food and Drug Administration. 1997. Food labeling; notification procedures for statements on dietary supplements. Fed Reg. 62:49883-49886.
   
31. Food and Drug Administration. 1997. Premarket notification for a new dietary ingredient. Fed. Reg. 62:49886-49892.
   
32. Food and Drug Administration. 1997. Current good manufacturing practice in manufacturing, packing, or holding dietary supplements. Fed. Reg. 62:5700-5709.
   
33. Food and Drug Administration. 1997. Dietary supplements containing ephedrine alkaloids. Fed. Reg. 62:30678-30724.
   
34. Food and Drug Administration. 1997. Food labeling: health claims; oats and coronary heart disease. Fed. Reg. 62:3584-3601.
   
35. Food and Drug Administration. 1997. Food labeling: health claims; soluble fiber from certain foods and coronary heart disease. Fed. Reg. 62:28234-28245.
   
36. Food and Drug Administration. 1996. Food labeling: health claims; sugar alcohols and dental caries. Fed. Reg. 61:43433-43447.
   
37. Food and Drug Administration. 1996. Food labeling: health claims and label statements; folate and neural tube defects. Fed. Reg. 61:8752-8781.
   
38. Food and Drug Administration. 1996. Premarket notification for a new dietary ingredient. Fed. Reg. 61:50774-50778.
   
39. Food and Drug Administration. 1996. Eligibility criteria for considering additional conditions in the over-the-counter drug monograph system; request for information and comments. Fed. Reg. 61:51625-51631.
   
40. Food and Drug Administration. 1995. Food labeling: reference daily intakes. Fed. Reg. 60:67164-67175.
   
41. Food and Drug Administration. 1995. Food labeling; requirements for nutrient content claims, health claims, and statements of nutritional support for dietary supplements. Fed. Reg. 60:67176-67184.
   
42. Food and Drug Administration. 1995. Food labeling; nutrient content claims: definition for "high potency" claim for dietary supplements and definition of "antioxidant" for use in nutrient content claims for dietary supplements and conventional foods. Fed. Reg. 60:67184-67194.
   
43. Food and Drug Administration. 1995. Food labeling; statement of identity, nutrition labeling and ingredient labeling of dietary supplements. Fed. Reg. 60:67194-67224.
   
44. Food and Drug Administration. 1995. Food labeling: nutrient content claims, general principles; health claims, general requirements and other specific requirements for individual health claims. Fed. Reg. 60:66206-66227.
   
45. Food and Drug Administration. 1994. Food labeling; general requirements for nutrition labeling for dietary supplements of vitamins, minerals, herbs, or other similar nutritional substances. Fed. Reg. 59:354-378.
   
46. Food and Drug Administration. 1994. Food labeling; requirements for nutrient content claims for dietary supplements of vitamins, minerals, herbs, and other similar nutritional substances. Fed. Reg. 59:378-395.
   
47. Food and Drug Administration. 1994. Food labeling; general requirements for health claims for dietary supplements. Fed. Reg. 59:395-426.
   
48. Food and Drug Administration. 1994. Center for Food Safety and Applied Nutrition's adverse reaction monitoring system (A.R.M.S.) standard operating procedures. Center for Food Safety and Applied Nutrition. Unpublished document. June. p. 4.
   
49. Food and Drug Administration. 1993. Regulation of dietary supplements. Fed. Reg. 58:33690-33700.
   
50. Food and Drug Administration. 1993. Food labeling; general requirements for health claims for dietary supplements. Fed. Reg. 58:33700-33715.
   
51. Food and Drug Administration. 1993 . Food labeling; general requirements for nutrition labeling for dietary supplements of vitamins, minerals, herbs, or other similar nutritional substances. Fed. Reg. 58:33715-33729.
   
52. Food and Drug Administration. 1993. Food labeling; requirements for nutrient content claims for dietary supplements of vitamins, minerals, herbs, and other similar nutritional substances. Fed. Reg. 58:33729-33751.
   
53. Food and Drug Administration. 1993. Antioxidant-vitamins and cancer and cardiovascular disease. Paper presented at public conference. National Institutes of Health. November 1-3.
   
54. Food and Drug Administration. 1993. Skin protectant drug products for over-the-counter human use; astringent drug products. Fed. Reg. 58:54458-54463.
   
55. Food and Drug Administration. 1991. Labeling; general requirements for health claims for food. Fed. Reg. 56:60537-60566.
   
56. Food and Drug Administration. 1991. Oral health care drug products for over-the-counter human use. Fed. Reg. 56:48342-48346.
   
57. Food and Drug Administration. 1987. Food labeling; public health messages and label statements. Proposed rules. Fed. Reg. 52:28843-28849.
   
58. Food and Drug Administration. 1986. Topical otic drug products for over-the-counter human use; final monograph. Fed. Reg. 51:28656-28661.
   
59. Food and Drug Administration. 1982. Topical otic drug products for over-the-counter human use; tentative final monograph. Fed. Reg. 47:30012-30021.
   
60. Food and Drug Administration. 1982. Oral health care drug products for over-the-counter human use; establishment of a monograph. Fed. Reg. 47:22760-22916.
   
61. Food and Drug Administration. 1982. Skin protectant drug products for over-the-counter human use; establishment of a monograph; and reopening of administrative record. Fed. Reg. 47: 39436-39447.
   
62. Food and Drug Administration. 1979. Vitamin and mineral drug products for over-the-counter human use. Fed. Reg. 44:16125-16200.
   
63. Food and Drug Administration. 1976. Over-the-counter drugs; establishment of a monograph for OTC cold, cough, allergy, bronchodilator and antiasthmatic products. Fed. Reg. 41:38314-38424.
   
64. Food and Drug Administration. 1973. Definitions and standards of identity for food for special dietary use. Fed. Reg. 38:20730-20740.
   
65. Food and Drug Administration. 1966. Dietary supplements and vitamin and mineral-fortified foods. Fed. Reg. 31:15730-15736.
   
66. Food and Drug Administration. 1941. Regulations for the enforcement of the Federal Food, Drug, and Cosmetic Act. Fed. Reg. 6:5921-5926.
   
67. Forbes, A.L. 1994. National nutrition policy, food labeling, and health claims. In: Shils, M.E; Olson, J.A.; Shike, M., eds. Modern nutrition in health and disease. 8th edition. Volume 2. Philadelphia, PA: Lea and Febiger. pp. 1649-1650.
   
68. Foster, S. ed. 1992. Herbs of Commerce. American Herbal Products Association, Bethesda, MD.
   
69. Freeman, F.; Kodera, Y. 1995. Garlic chemistry: stability of S-(2-propenyl) 2-propene-1-sulfinothioate (allicin) in blood, solvents, and simulated physiological fluids. J. Agri. Food Chem. 43:2332-2338.
   
70. Gericke, N. 1995. The regulation and control of traditional herbal medicines: an international overview with recommendations for the development of a South African approach. Working document. Cape Town, South Africa: Traditional Medicines Programme, University of Cape Town.
   
71. Girardi, F.A. 1997. Director for Marketing Services and Regulatory Affairs. Hoffman-La Roche Inc. Supplement to oral testimony presented to the Commission on Dietary Supplement Labels. January 8. Washington, DC.
   
72. Girardi, F.A. 1996. Director for Marketing Services and Regulatory Affairs. Hoffman-La Roche Inc. Oral testimony presented to the Commission on Dietary Supplement Labels. June 6. Orlando, FL.
   
73. Grell, C. 1996. Law offices of Christopher E. Grell. Written testimony submitted to the Commission on Dietary Supplement Labels. June 12. October 29. November 12.
   
74. Interagency Committee on Human Nutrition Research. 1996. The human nutrition research and information management system. Fiscal year 1994. 13th progress report. National Institutes of Health.
   
75. Howard, R. 1996. President. National Nutritional Foods Association. Oral testimony presented to the Commission on Dietary Supplement Labels. February 16. Washington, DC.
   
76. Ippolito, P.; Mathios, A. 1989. Health claims in advertising and labeling; a study of the cereal market. Staff report. Bureau of Economics. Federal Trade Commission.
   
77. Israelsen, L. 1996. President. Utah Natural Products Alliance. Oral testimony presented to the Commission on Dietary Supplement Labels. March 8. Salt Lake City, UT.
   
78. Kessler, D.A. 1993. Introducing MedWatch. A new approach to reporting medication and device adverse effect and product problems. JAMA. 269:2765-2768.
   
79. Kessler, D.A. 1993 Changing the culture of medicine: The Food and Drug Administration's MedWatch program. Acad. Med. 68:776-777.
   
80. Keystone Center. 1996. The final report of the Keystone national policy dialogue on food, nutrition, and health. Keystone, CO and Washington, DC.
81. Kissane, K. 1993. Herbal hazards—health. The age. Melbourne: November 24. As cited by Nozari, F. 1994. p. 16.
   
82. Krebs-Smith, J. 1997. Personal communication to K.D. Fisher, September 28, 1997. (FY95 expenditures, projects, and obligations for nutrition research).
   
83. Levy, A.S. 1995. Summary report on health claims focus groups. Division of Market Studies. Center for Food Safety and Applied Nutrition. Food and Drug Administration. Washington, DC. Appendix D In: Keystone Center. 1996. The final report of the Keystone national policy dialogue on food, nutrition, and health. Keystone, CO and Washington, DC.
   
84. Levy, A.S.; Derby, B.M.; Roe, B.E. 1997. Consumer impacts of health claims: an experimental study. Division of Market Studies. Center for Food Safety and Applied Nutrition. Food and Drug Administration. Available from: http://vm.cfsan.FDA.gov/~dms/hclm-sum.html. Also cited in Fed. Reg. 62:3635-3636.
   
85. Lichter, R.; Amundson, D.R. 1996. Food for thought; reporting of diet, nutrition and food safety May 1995-July 1995. Prepared for International Food Information Council Foundation. Center for Media and Public Affairs.
   
86. Mattocks, A.R. 1986. Chemistry and toxicology of pyrrolizidine alkaloids. New York: Academic Press.
   
87. McGuffin, M. 1996. President. American Herbal Products Association. Oral testimony presented to the Commission on Dietary Supplement Labels. April 26. San Francisco, CA.
   
88. McNamara, S.H. 1996. FDA regulation of ingredients in dietary supplements after passage of the Dietary Supplement Health and Education Act of 1994: an update. Food and Drug Law J. 51:313-318.
   
89. McNamara, S.H. 1995. Dietary supplements of botanicals and other substances: a new era of regulation. Food and Drug Law J. 50:341-355.
   
90. Mengs, U.; Lang, W.; Poach. J.A. 1982. The carcinogenic action of aristolochic acids in rats. Arch. Toxicol. 51:107-119.
   
91. National Council for Improved Health v. Shalala, 1997 U.S. App. LEXIS 21180 (10 Cir. Aug. 11, 1997).
   
92. Nutritional Health Alliance v. Shalala, 953 F. Supp. 526 (S.D.N.Y. 1997).
   
93. National Nutritional Foods Association v. Kennedy, 572 F.2d 377 (2nd Cir. 1978).
   
94. National Nutritional Foods Association et. al. v. Food and Drug Administration, Department of Health, Education, and Welfare, et. al., 504 F.2d 761 (2nd Cir. 1974), cert. denied, 420 U.S. 946 (1975).
   
95. Nozari, F. 1994. Dietary supplements. Report to Congress. LL94-3. Washington, DC.
   
96. Office of the Federal Register. 1997. Code of Federal Regulations. Imminent hazard to the public health. Title 21: food and drugs, part 2.5 rev. Washington, DC: U.S. Government Printing Office.
   
97. Office of the Federal Register. 1997. Code of Federal Regulations. Food labeling. Title 21: food and drugs, part 101 rev. Washington, DC: U.S. Government Printing Office.
   
98. Office of the Federal Register. 1997. Code of Federal Regulations. Nutrient content claims-general principles. Title 21: food and drugs, part 101.13 rev. Washington, DC: U.S. Government Printing Office.
   
99. Office of the Federal Register. 1997. Code of Federal Regulations. Health claims: general requirements. Title 21: food and drugs, part 101.14 rev. Washington, DC: U.S. Government Printing Office.
   
100. Office of the Federal Register. 1997. Code of Federal Regulations. Health claims: general requirements. Title 21: food and drugs, part 101.14 (a)(6) rev. Washington, DC: U.S. Government Printing Office.
   
101. Office of the Federal Register. 1997. Code of Federal Regulations. Health claims: general requirements. Title 21: food and drugs, part 101.14 (b) (3) (ii) rev. Washington, DC: U.S. Government Printing Office.
   
102. Office of the Federal Register. 1997. Code of Federal Regulations. Food labeling warning and notice statements. Title 21: food and drugs, part 101.17 rev. Washington, DC: U.S. Government Printing Office.
   
103. Office of the Federal Register. 1997. Code of Federal Regulations. Food; designation of ingredients. Title 21: food and drugs, part 101.4 rev. Washington, DC: U.S. Government Printing Office.
   
104. Office of the Federal Register. 1997. Code of Federal Regulations. Petitions for health claims. Title 21: food and drugs, part 101.70 rev. Washington, DC: U.S. Government Printing Office.
   
105. Office of the Federal Register. 1997. Code of Federal Regulations. Health claims: calcium and osteoporosis. Title 21: food and drugs, part 101.72 rev. Washington, DC: U.S. Government Printing Office.
   
106. Office of the Federal Register. 1997. Code of Federal Regulations. Health claims: folate and neural tube defects. Title 21: food and drugs, part 101.79 rev. Washington, DC: U.S. Government Printing Office.
   
107. Office of the Federal Register. 1997. Code of Federal Regulations. Health claims: soluble fiber from whole oats and risk of coronary heart disease (CHD). Title 21: food and drugs, part 101.81 rev. Washington, DC: U.S. Government Printing Office.
   
108. Office of the Federal Register. 1997. Code of Federal Regulations. Current good manufacturing practice in manufacturing, packing, or holding human food. Title 21: food and drugs, part 110 rev. Washington, DC: U.S. Government Printing Office.
   
109. Office of the Federal Register. 1997. Code of Federal Regulations. Natural flavoring substances and natural substances used in conjunction with flavors. Title 21: food and drugs, part 172.510 rev. Washington, DC: U.S. Government Printing Office.
   
110. Office of the Federal Register. 1997. Code of Federal Regulations. Spices and other natural seasonings and flavorings. Title 21: food and drugs, part 182.10 rev. Washington, DC: U.S. Government Printing Office.
   
111. Office of the Federal Register. 1997. Code of Federal Regulations. Essential oils, oleoresin (solvent free), and natural extractives (including distillates). Title 21: food and drugs, part 182.20 rev. Washington, DC: U.S. Government Printing Office.
   
112. Office of the Federal Register. 1997. Code of Federal Regulations. Natural extractives (solvent-free) used in conjunction with spices, seasonings, and flavorings. Title 21: food and drugs, part 182.40 rev. Washington, DC: U.S. Government Printing Office.
   
113. Office of the Federal Register. 1997. Code of Federal Regulations. Certain other spices, seasonings, essential oils, oleoresin, and natural extracts. Title 21: food and drugs, part 182.50 rev. Washington, DC: U.S. Government Printing Office.
   
114. Office of the Federal Register. 1997. Code of Federal Regulations. Postmarketing reporting of adverse drug experiences. Title 21: food and drugs, part 314.80 rev. Washington, DC: U.S. Government Printing Office.
   
115. Office of the Federal Register. 1997. Code of Federal Regulations. Adequate and well-controlled studies. Title 21: food and drugs, part 314.126 rev. Washington, DC: U.S. Government Printing Office.
   
116. Office of the Federal Register. 1997. Code of Federal Regulations. Procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded, and for establishing monographs. Title 21: food and drugs, part 330.10 rev. Washington, DC: U.S. Government Printing Office.
   
117. Office of the Federal Register. 1997. Code of Federal Regulations. Procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded, and for establishing monographs. Title 21: food and drugs, part 330.10 (4) (i) rev. Washington, DC: U.S. Government Printing Office.
   
118. Office of the Federal Register. 1997. Code of Federal Regulations. Procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded, and for establishing monographs. Title 21: food and drugs, part 330.10 (4) (ii) rev. Washington, DC: U.S. Government Printing Office.
   
119. Office of the Federal Register. 1997. Code of Federal Regulations. Labeling of cosmetic products for which adequate substantiation of safety has not been obtained. Title 21: food and drugs, part 740.10 Washington, DC: U.S. Government Printing Office.
   
120. Perharic, L.; Shaw, D.; Colbridge, M.; House, I.; Leon, C.; Murray,V. 1994. Toxicological problems resulting from exposure to traditional remedies and food supplements. Drug Safety 11:284-294.
   
121. Pharmaceutical Affairs Bureau, Ministry of Health and Welfare. Japan. 1987. Manual for monitoring and supervising unapproved or unlicensed medical and pharmaceutical products. pp. 1-68.
   
122. P inco, R.G.; Rubin, P.D. 1996. Ambiguities of the Dietary Supplement Health and Education Act of 1994. Food and Drug Law J. 51:383-405.
   
123. Porter, D.V. 1995. Dietary supplements: recent chronology and legislation. Nutr. Rev. 53: 31-36.
   
124. Porter, D.V. 1995. Dietary Supplement Health and Education Act of 1994: PL 103-417. Nutrition Today 30: 89-94.
   
125. Porter, D.V. 1994. Congressional Research Service report for Congress: Dietary Supplement Health and Education Act of 1994, PL 103-417.
   
126. Porter, D.V.; Earl, R.O. 1992. Food labeling toward national uniformity. Committee on State Food Labeling. Food and Nutrition Board. Institute of Medicine. Washington, DC: National Academy Press.
   
127. Roe, B.E.; Derby, B.M.; Levy, A.S. 1997. Demographic, lifestyle and information use characteristics of dietary supplement user segments. Division of Market Studies. Center for Food Safety and Applied Nutrition. Food and Drug Administration. Unpublished study transmitted via memorandum by A.S. Levy to K.D. Fisher. March 12.
   
128. Scarborough, E. 1995. Labeling: current issues and policy decisions. Paper presented at the 39th annual educational conference. December 12. Food and Drug Law Institute.
   
129. Schultz, W.B. 1996. Health claims petition—dietary calcium and hypertension. Food and Drug Administration Docket No. 96-P-0047.
   
130. Slesinski, M.J.; Subar, A.F.; Kahle, L.L. 1995. Trends in use of vitamin and mineral supplements in the United States: the 1987 and 1992 national health interview surveys. J. Am. Dietetic Assoc. 95:921-923.
   
131. Sloan, A.E.; Stiedeman, M.; Barr, A. 1996. Health enhancing ingredients. North Palm Beach, FL: Applied Biometrics.
   
132. Srinivasan, V. 1997. Personal communication with K.D. Fisher. March 27.
   
133. Takiura, M.; Amagase, H. 1997. Comments submitted to the Commission on Dietary Supplement Labels regarding the draft report. August 4.
   
134. United States Congress. 1994. Statement of agreement. Congressional Record—Senate. October 7. S14801. House. October 6. H1180.
   
135. United States Department of Agriculture; United States Department of Health and Human Services. 1995. Nutrition and your health: dietary guidelines for Americans. 4th edition. Washington, DC: U.S. Government Printing Office.
   
136. United States Senate. 1994. Report 103-410. Dietary Supplement Health and Education Act of 1994. 103rd Congress. 2nd session.
137. Upton, R. 1992. Regulations of herbal products abroad: submission to the Office of Technology Assessment. U.S. Congress. Written material submitted to the Commission on Dietary Supplement Labels. October 28, 1996.
   
138. U.S. v. Lexington Mill & Elevator Co., 232 U.S. 399 (1914).
   
139. Weinberger et. al. v. Bentex Pharmaceuticals, Inc. et. al. 412 U.S. 645 (1973)
   
140. World Health Organization. 1996. World Health Organization draft monographs on botanicals. Geneva, Switzerland.
   
141. World Health Organization. 1991. Guidelines for the assessment of herbal remedies. Document prepared at the World Health Organization Consultation in Munich, Germany. June 19-21. Geneva, Switzerland.
   
142. Wright, J. 1997. Letter containing tables of estimates with the prevalence of use of dietary supplements from NHANES III, 1988-94. Letter sent to K.D. Fisher. April 30.
   
143. Wright, P.B. 1997. Director, Pharmacology and Toxicology. Nonprescription Drug Manufacturers Association. Written testimony submitted to the Commission on Dietary Supplement Labels. March 4. Baltimore, MD.
   
144. Xinhua News Agency. 1996. Crackdown on poor health food planned next year. Item Number: 1224031. December 24. Beijing.

Previous (Chapter IV) | TOC | Next (Appendix A)

Commission on Dietary Supplement Labels